856 related articles for article (PubMed ID: 25783794)
1. Mitochondrial plasticity in cancer-related muscle wasting: potential approaches for its management.
Vitorino R; Moreira-Gonçalves D; Ferreira R
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):226-33. PubMed ID: 25783794
[TBL] [Abstract][Full Text] [Related]
2. Muscle wasting in cancer: the role of mitochondria.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):221-5. PubMed ID: 25769061
[TBL] [Abstract][Full Text] [Related]
3. Muscle wasting: is mitochondrial dysfunction a key target?
Attaix D; Pichard C; Baracos VE
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):213-4. PubMed ID: 25807356
[No Abstract] [Full Text] [Related]
4. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise.
Al-Majid S; Waters H
Biol Res Nurs; 2008 Jul; 10(1):7-20. PubMed ID: 18705151
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting.
Antunes D; Padrão AI; Maciel E; Santinha D; Oliveira P; Vitorino R; Moreira-Gonçalves D; Colaço B; Pires MJ; Nunes C; Santos LL; Amado F; Duarte JA; Domingues MR; Ferreira R
Biochim Biophys Acta; 2014 Jun; 1841(6):896-905. PubMed ID: 24657703
[TBL] [Abstract][Full Text] [Related]
6. Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia.
Khamoui AV; Kim JS
Eur J Cancer Care (Engl); 2012 Mar; 21(2):143-57. PubMed ID: 21880081
[TBL] [Abstract][Full Text] [Related]
7. Cachexia and sarcopenia: mechanisms and potential targets for intervention.
Argilés JM; Busquets S; Stemmler B; López-Soriano FJ
Curr Opin Pharmacol; 2015 Jun; 22():100-6. PubMed ID: 25974750
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.
Carson JA; Hardee JP; VanderVeen BN
Semin Cell Dev Biol; 2016 Jun; 54():53-67. PubMed ID: 26593326
[TBL] [Abstract][Full Text] [Related]
9. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations.
Ballarò R; Beltrà M; De Lucia S; Pin F; Ranjbar K; Hulmi JJ; Costelli P; Penna F
FASEB J; 2019 Apr; 33(4):5482-5494. PubMed ID: 30653354
[TBL] [Abstract][Full Text] [Related]
10. Cancer cachexia.
Tisdale MJ
Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
[TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.
Constantinou C; Fontes de Oliveira CC; Mintzopoulos D; Busquets S; He J; Kesarwani M; Mindrinos M; Rahme LG; Argilés JM; Tzika AA
Int J Mol Med; 2011 Jan; 27(1):15-24. PubMed ID: 21069263
[TBL] [Abstract][Full Text] [Related]
12. Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function.
Penna F; Ballarò R; Martinez-Cristobal P; Sala D; Sebastian D; Busquets S; Muscaritoli M; Argilés JM; Costelli P; Zorzano A
J Mol Biol; 2019 Jul; 431(15):2674-2686. PubMed ID: 31150737
[TBL] [Abstract][Full Text] [Related]
13. Cancer-induced fatigue and skeletal muscle wasting: the role of exercise.
al-Majid S; McCarthy DO
Biol Res Nurs; 2001 Jan; 2(3):186-97. PubMed ID: 11547540
[TBL] [Abstract][Full Text] [Related]
14. A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes.
Daly LE; Prado CM; Ryan AM
Proc Nutr Soc; 2018 May; 77(2):135-151. PubMed ID: 29745361
[TBL] [Abstract][Full Text] [Related]
15. [Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].
Argilés JM; Busquets S; López-Soriano FJ; Figueras M
Nutr Hosp; 2006 May; 21 Suppl 3():38-45. PubMed ID: 16768029
[TBL] [Abstract][Full Text] [Related]
16. Baicalin supplementation reduces serum biomarkers of skeletal muscle wasting and may protect against lean body mass reduction in cancer patients: Results from a pilot open-label study.
Emanuele E; Bertona M; Pareja-Galeano H; Fiuza-Luces C; Morales JS; Sanchis-Gomar F; Lucia A
Neuro Endocrinol Lett; 2016 Jul; 37(3):213-216. PubMed ID: 27618596
[TBL] [Abstract][Full Text] [Related]
17. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
Arneson PC; Doles JD
Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
[TBL] [Abstract][Full Text] [Related]
19. Clinical results in cachexia therapeutics.
Crawford J
Curr Opin Clin Nutr Metab Care; 2016 May; 19(3):199-204. PubMed ID: 26974316
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin: from discovery to cancer cachexia therapy.
Molfino A; Formiconi A; Rossi Fanelli F; Muscaritoli M
Curr Opin Clin Nutr Metab Care; 2014 Sep; 17(5):471-6. PubMed ID: 24905862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
